HeartBeat.bio AG
@heartbeat.bio
HeartBeat.bio is a pioneering TechBio company leveraging a next-generation drug discovery platform to develop breakthrough medicines for heart failure patients. Heart failure is a rapidly growing global health crisis, affecting over 30 million people in major pharmaceutical markets, with limited treatment options. Despite its prevalence, innovation in this space has lagged—creating a massive opportunity for disruption. Our proprietary Cardioid Drug Discovery Platform integrates iPSC-derived cardiac organoids with AI-driven analytics and advanced automation. Unlike traditional drug discovery, which relies heavily on animal models with poor clinical translatability, our human-centric approach enables more predictive, efficient, and cost-effective drug development. By combining physiologically relevant human models with cutting-edge technology, we aim to accelerate drug discovery, reduce failure rates, and bring novel therapies to patients faster. We are advancing our own pipeline while strategically partnering with pharma and biotech companies to co-develop transformative heart failure treatments. Recently, we closed our first longer-term partnership deal with a leading player in cardiovascular disease. Initial focus areas include cardiomyopathies, myocardial fibrosis, and cardiac remodeling—high-impact indications with significant unmet needs.
HeartBeat.bio AG's Company Logos
HeartBeat.bio AG's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#E40035
Red Ribbon
228, 0, 53
346, 100, 45
0, 100, 77, 11
#E4586A
Mandy
228, 88, 106
352, 72, 62
0, 61, 54, 11
#002B59
Prussian Blue
0, 43, 89
211, 100, 17
100, 52, 0, 65
About HeartBeat.bio AG
HeartBeat. bio AG is a revolutionary brand that aims to reinvent the process of cardiac drug discovery. Through the convergence of cutting-edge human organoid technologies, hardware engineering, and artificial intelligence, HeartBeat.
bio is dedicated to changing the landscape of cardiac drug development. The company is driven by a mission to radically transform the traditional paradigm, aiming to improve the efficiency and effectiveness of cardiac drug research. With a focus on innovative solutions, HeartBeat.
bio is at the forefront of the industry, pioneering new approaches to enhance the development of life-saving medications. Located at Vienna Biocenter 6 Dr. Bohr-Gasse 7 in Vienna, HeartBeat.
bio AG is committed to pushing the boundaries of scientific advancements in the field of cardiology. For more information, contact their dedicated team at office@heartbeat. bio.
Discover a new era of cardiac drug discovery with HeartBeat. bio
Company type
Privately Held
Year founded
2021
Company size
11-50 employees
